Medtronic plc offers the O-arm surgical imaging system for diagnostic and intraoperative imaging applications. The increasing adoption of its O-arm surgical imaging system for image-guided surgeries is primarily responsible for its share in the global CT scanner market. However, the recall of its product in the U.S. is expected to limit the revenue generation from the U.S. market and thereby hindering its growth in the overall CT scanner market (as the U.S. commands the largest market share in global CT scanner market). For instance, in October 2016, U.S. FDA initiated Class 2 Device Recall of its O-arm Surgical Imaging system due to inaccuracy in stealth station navigated images.